{"name": "Cancer Therapeutics",
 "permalink": "cancer-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/cancer-therapeutics",
 "homepage_url": "http://www.cancer-therapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": null,
 "number_of_employees": null,
 "founded_year": null,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "",
 "description": "",
 "created_at": "Tue Jan 26 11:24:53 UTC 2010",
 "updated_at": "Tue Jan 26 11:29:43 UTC 2010",
 "overview": "\u003Cp\u003ECancer Therapeutics is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology.  It seeks out disruptive cancer research and technology opportunities to invest in, develop, and commercialize.  The end result will be therapies, treatments, and pharmaceuticals targeted at more efficiently and effectively attacking cancer.  CTI seeks partners to co-develop drugs in various stages in their pipeline.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       32],
      "assets/images/resized/0007/4889/74889v1-max-150x150.jpg"],
     [[250,
       53],
      "assets/images/resized/0007/4889/74889v1-max-250x250.jpg"],
     [[306,
       66],
      "assets/images/resized/0007/4889/74889v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [],
 "milestones":
  [{"description": "CANCER THERAPEUTICS FINALIZES DEFINITIVE AGREEMENT WITH NANOTHERAPIES, LLC",
    "stoned_year": 2009,
    "stoned_month": 5,
    "stoned_day": 28,
    "source_url": "http://www.cancer-therapeutics.com/pr5_28_09.html",
    "source_text": "",
    "source_description": "CANCER THERAPEUTICS FINALIZES DEFINITIVE AGREEMENT WITH NANOTHERAPIES, LLC",
    "stoneable_type": "Company",
    "stoned_value": null,
    "stoned_value_type": null,
    "stoned_acquirer": null,
    "stoneable":
     {"name": "Cancer Therapeutics",
      "permalink": "cancer-therapeutics"}}],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}